Overview

Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation

Status:
Completed
Trial end date:
2019-07-23
Target enrollment:
Participant gender:
Summary
Extend evaluation of deferasirox film-coated tablet (FCT) formulation
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Deferasirox